Viral Immunology Group lead new Omicron vaccine trial

June 21, 2022

Associate Professor Branka Grubor-Bauk, Professor Eric Gowans and their Viral Immunology Group at the BHI, TQEH are leading a new COVID-19 vaccine trial that targets the Omicron variant. Participants over the age of 18 who were triple-vaccinated over three months ago, and who have not had COVID-19, may be eligible to participate:

Full story at The University of Adelaide Newsroom.

Listen to Branka’s interview on ABC Radio here (from 2:02:27).

Link to Channel 9 news story via BHI Facebook page.

Below is the newspaper article from the Sunday Mail on Sunday 19 June 2022.

Return to News